Navigation Links
Rare surgery performed to remove pancreas, prevent diabetes

In a 12-hour, dual-stage surgery known to be performed at only two other centers in the U.S., doctors at the University of Alabama at Birmingham on Tuesday returned a patient's own insulin-producing cells to him after surgically removing his pancreas to eliminate constant, severe pain from chronic pancreatitis.

The patient, Leonard Stewart, 47, of Panama City, Fla., remained anesthetized in the operating room at UAB Hospital through removal of his entire pancreas and the hours-long wait for the pancreatic islet cells to be processed in a specialized UAB laboratory. The cells were then returned to the operating room and infused into the patient's liver, where they have begun to produce insulin.

Few hospitals have the technologically sophisticated facilities necessary to isolate and purify the pancreatic islet cells either from a cadaver donor for transplantation or, as in this case, for infusion back into the same patient.

The removal of the entire pancreas is an accepted, although radical last-resort, surgery to give relief from pain, usually from inflammation of pancreatitis. In the past, such surgery might eliminate the pain but would leave the patient with severe, poorly-controlled diabetes, since the insulin-producing islets of Langerhans would necessarily be discarded along with the rest of the organ. Patients without functioning islet cells have to take insulin for life. Retrieving and relocating the natural insulin-producing cells from the pancreas saves patients from the complications of severe, poorly-controlled diabetes. Loss of the other major function of the pancreas, production of digestive enzymes, is dealt with by taking the enzymes as a dietary supplement.

Leading the complex operation were Drs. Selwyn M. Vickers, Devin E. Eckhoff and Juan L. Contreras. Vickers, who removed the pancreas, directs a clinic for the management of chronic pancreatitis, is chief of gastrointestinal surgery and co-director of the UAB Pancreati cobiliary Center. Eckhoff is director of the division of transplantation, and directs the University's islet cell transplant program, which uses pancreatic cells from brain-dead patients to cure insulin-dependent diabetics. Contreras is co-director of the islet transplant program. The patient was in intensive care at UAB Hospital for two days following the surgery, and will be in the hospital until sometime next week, doctors said.

Stewart's chronic pancreatitis developed four years ago as the result of a congenitally malformed pancreatic duct that closed down following removal of his gallbladder at a Louisiana hospital. Three prior operations and several procedures to place stents in the pancreatic duct failed to provide relief. The pain of chronic pancreatitis is known to be constant and extremely debilitating. Facing a life of suffering from the condition, Stewart chose the alternative of total removal of the pancreas and of autologous islet cell transplantation.

The procedure has been done previously; the first case was 16 years ago at the University of Minnesota, and the patient still survives. Only a few other cases were attempted, and results were not uniformly good, so the procedure fell out of favor until recently, when new advances in cadaveric islet cell transplantation made outcomes more favorable.


'"/>

Source:University of Alabama at Birmingham


Related biology news :

1. Scalpel-free surgery could reduce risk of HIV and hepatitis exposure for health care workers
2. 3D ultrasound device poised to advance minimally invasive surgery
3. For one Stanford doctor, the beat goes on during open-heart surgery
4. Unique equine cataract surgery offered on routine basis
5. Cheaper and simpler keyhole surgery
6. Robot assisted surgery more accurate than conventional surgery
7. U of MN uses robotic surgery techniques in cardiac cell therapy research
8. New biologic treatment for tennis elbow may replace surgery for chronic sufferers
9. Jefferson scientists find high glucose before surgery raises risk of dangerous complications
10. Successful lung cancer surgery not enough to break nicotine dependence in many smokers
11. Computer scientists unravel language of surgery
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/3/2016)... May 3, 2016  Neurotechnology, a provider of ... MegaMatcher Automated Biometric Identification System (ABIS) , a ... projects. MegaMatcher ABIS can process multiple complex biometric ... combination of fingerprint, face or iris biometrics. It ... and MegaMatcher Accelerator , which have ...
(Date:4/19/2016)... The new GEZE SecuLogic access ... "all-in-one" system solution for all door components. It can ... door interface with integration authorization management system, and thus ... minimal dimensions of the access control and the optimum ... offer considerable freedom of design with regard to the ...
(Date:3/31/2016)... March 31, 2016   ... or the "Company") LegacyXChange is excited to ... its soon to be launched online site for trading ... ) will also provide potential shareholders a sense ... technology to an industry that is notorious for fraud. ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... 2016 , ... Cancer experts from Austria, Hungary, Switzerland, and ... new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma has just published ... , Biomarkers are components in the blood, tissue or body fluids that ...
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... ... , ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension ... are higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... bottom of the cuvette holder. , FireflySci has developed several Agilent flow cell ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
Breaking Biology Technology: